| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.36▼ | 1.36▼ | 1.36▼ | 1.37▼ | 1.49▼ |
| MA10 | 1.36▼ | 1.36▼ | 1.39▼ | 1.39▼ | 1.54▼ |
| MA20 | 1.36▼ | 1.39▼ | 1.37▼ | 1.48▼ | 2.07▼ |
| MA50 | 1.36▼ | 1.37▼ | 1.37▼ | 1.57▼ | 2.53▼ |
| MA100 | 1.38▼ | 1.37▼ | 1.44▼ | 2.16▼ | 2.03▼ |
| MA200 | 1.38▼ | 1.45▼ | 1.54▼ | 2.65▼ | 1.41▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.005▼ | -0.003▼ | 0.001▲ | -0.065▼ |
| RSI | 44.143▼ | 44.373▼ | 46.397▼ | 37.323▼ | 27.912▼ |
| STOCH | 43.332 | 19.456▼ | 11.009▼ | 27.587 | 13.064▼ |
| WILL %R | -50.000 | -90.000▼ | -90.000▼ | -77.401▼ | -96.842▼ |
| CCI | -12.484 | -48.933 | -77.248 | -40.427 | -83.290 |
|
Monday, January 12, 2026 05:56 AM
Positioned to increase depth of Vafseo prescribing entering 2026 with access to approximately 275,000 patients First patient dosed in Praliciguat Phase 2 clinical trial studying focal segmental ...
|
|
Monday, January 05, 2026 01:27 PM
Each stock option has a 10-year term and is subject to the terms and conditions of Akebia’s inducement award program and a stock option agreement covering the grant. Akebia Therapeutics, Inc. is a ...
|
|
Sunday, December 28, 2025 04:46 AM
Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in. On December 1, Akebia Therapeutics announced the official establishment of its rare kidney disease pipeline. This ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/01/26 | 1.45 | 1.45 | 1.35 | 1.36 | 4,175,539 |
| 22/01/26 | 1.36 | 1.45 | 1.36 | 1.44 | 2,373,119 |
| 21/01/26 | 1.35 | 1.39 | 1.33 | 1.37 | 2,105,535 |
| 20/01/26 | 1.32 | 1.36 | 1.30 | 1.34 | 2,463,427 |
| 16/01/26 | 1.34 | 1.41 | 1.335 | 1.36 | 2,766,774 |
| 15/01/26 | 1.38 | 1.39 | 1.33 | 1.34 | 2,478,880 |
| 14/01/26 | 1.37 | 1.42 | 1.3405 | 1.38 | 3,215,626 |
| 13/01/26 | 1.41 | 1.41 | 1.31 | 1.38 | 4,544,398 |
| 12/01/26 | 1.49 | 1.49 | 1.36 | 1.40 | 6,780,785 |
| 09/01/26 | 1.50 | 1.54 | 1.48 | 1.52 | 2,647,270 |
|
|
||||
|
|
||||
|
|